This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignee: Cancer Research Technology Limited. Active years: 2013-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2015
Title: Danielle Dicara: Innovator in Peptide Ligands
Introduction
Danielle Dicara is a prominent inventor based in London, GB. She has made significant contributions to the field of peptide ligands, particularly in relation to their applications in medical treatments. With a total of 2 patents, her work is paving the way for advancements in the treatment of diseases mediated by AVβ6.
Latest Patents
Danielle's latest patents include the development of AVβ6 peptide ligands and their uses. These patents disclose AVβ6 peptide ligands, functional variants thereof, and their nucleic acids encoding them. The applications of these innovations are focused on the treatment and imaging of AVβ6 mediated diseases, showcasing her commitment to improving healthcare outcomes.
Career Highlights
Danielle works at Cancer Research Technology Limited, where she continues to push the boundaries of scientific research. Her role at this esteemed organization allows her to collaborate with other experts in the field and contribute to groundbreaking discoveries.
Collaborations
Some of her notable coworkers include Mark Howard and John Marshall. Their collective expertise enhances the innovative environment at Cancer Research Technology Limited, fostering collaboration that leads to significant advancements in cancer research.
Conclusion
Danielle Dicara is a trailblazer in the field of peptide ligands, with her patents reflecting her dedication to medical innovation. Her work at Cancer Research Technology Limited and collaborations with esteemed colleagues further solidify her impact on the scientific community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile